Mary Tanner is senior managing director at Burrill Securities. She was formerly senior managing director at Lehman Brothers and managing director at Peter J. Solomon; her work on countless deals includes biotech's second-ever initial public offering and the Roche-Genentech merger. In her conversation with Nature Biotechnology, Tanner details the Amgen-Immunex buyout, defines 'wildcatting' and suggests the years in which children most need a parent around the house. http://www.nature.com/nbt/podcast/index.html.